Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you make the most of staying home.
Visit the hub

In this April 29, 2020, file photo, a man gets tested for the novel coronavirus, in Johannesburg, South Africa.

Jerome Delay/The Associated Press

South Africa says it has a backlog of nearly 100,000 unprocessed tests for the coronavirus, a striking example of the painful shortage of testing kits and reagents across Africa as cases steadily rise.

“This challenge is caused by the limited availability of test kits globally,” the health ministry said in a statement overnight, putting the backlog at 96,480 as of Monday. Priority is given to processing tests from patients admitted to hospitals and health workers, it said.

South Africa has conducted more tests for the virus than any other country in Africa – more than 655,000 – and has the most confirmed cases with 27,403.

Story continues below advertisement

One of the latest to die of COVID-19 in South Africa was a National Health Laboratory Services employee. “We understand this tragedy will certainly test you,” the ministry said in a message to her colleagues, adding that the government is committed to providing proper protective gear.

That, too, faces shortages across Africa. More than 3,400 health workers on the continent had been infected as of a week ago, according to the World Health Organization.

The shortages, especially in testing materials, have jolted African authorities into facing uncomfortable truths: Richer countries are elbowing them out in the race to obtain crucial supplies, and the continent relies almost entirely on imports for drugs and other medical items.

“We have to have Made in Africa products,” the director of the Africa Centers for Disease Control and Prevention, John Nkengasong, told reporters Thursday. “We cannot keep importing basic things.”

He and others, including the WHO’s Ethiopian director-general, have raised the cry for fair access, including for any vaccine or treatment that emerges.

“Dozens of countries have imposed export controls on medical supplies and equipment,” scores of South African and other health and activist groups said in an open letter to Group of 20 leaders last month.

Complicating matters are global powers like the United States and China promoting aid to African countries during the pandemic as part of efforts to win support on the continent. But that aid doesn’t always show up.

Story continues below advertisement

President Donald Trump on May 21 said “we just sent 1,000” ventilators to Nigeria, but the country’s information minister, Lai Mohammed, told reporters Thursday that “to the best of my knowledge they have not arrived. When they do arrive, it will be made public.”

But the testing shortages are especially frustrating for African health officials, who have been praised for swiftly expanding testing capability for the virus continentwide, from just two countries in February.

“Low levels of testing might be artificially lowering apparent infection rates,” The Lancet said in a new editorial noting Africa’s quick response but also the challenges that lie ahead.

Across Africa slightly under 2 million tests for the virus have been conducted, Nkengasong said, far below the target of testing 13 million people – or 1 per cent of the continent’s population of 1.3 billion.

Nigeria, Africa’s most populous country with some 200 million people, has one of the lowest coronavirus testing rates in the world with 286 tests per million people. More than 58,000 tests for the virus have been conducted, according to the country’s Center for Disease Control. Nearly 9,000 cases have been confirmed while worries grow about undetected spread of the virus in the north.

In Ethiopia, Africa’s second most populous country with some 110 million people, the health ministry says more than 96,000 tests have been conducted. More than 830 cases have been confirmed.

Story continues below advertisement

As of mid-May, Chad had carried out 105 tests per million people and Mali had tested just 173 per million, compared to some 38,000 tests per million in the United States, the International Rescue Committee said last week.

By the end of this week 2.5 million tests will have been distributed to Africa’s 54 countries, the Africa CDC’s Nkengasong said.

Despite the shortages, “I’m optimistic that in the next two to three weeks it will be very different,” he said, without giving details.

So far African nations have relied on tests donated by the Jack Ma Foundation, sourced via partners including the WHO and procured via a newly created platform that pools African countries’ purchasing efforts on the international market.

Meanwhile, efforts at domestic production of testing materials have begun in South Africa, Morocco, Senegal and Kenya, the Africa CDC has said, with plans to have those countries aid each other in evaluating the products.

“Africa is a continent that needs its own internal capacity to produce diagnostic kits,” South African Health Minister Zweli Mkhize told reporters on Thursday. “We need several millions of these kits.”

Story continues below advertisement

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies